Delayed Onset Muscle SorenessNCT06535906
Effect of Manual Lymphatic Drainage and Kinesio Taping on Delayed Onset Muscle Soreness
A study testing kinesio taping and manual lymph drainage in people with Delayed Onset Muscle Soreness, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).
Trial summary
Delayed muscle soreness is pain and tenderness that occurs after unusual exercises, most often involving eccentric contraction. This sensitivity, which usually begins in the distal part of the muscle and is intense, spreads progressively throughout the entire muscle 24-48 hours after exercise. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Delayed Onset Muscle Soreness
- What is being tested?
- kinesio taping and manual lymph drainage
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 48 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 23 Sep 2024to 18 Oct 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Being between the ages of 18-40
- Agreeing to participate in the study
- Being healthy sedentary
Who cannot join
- Those with neurological or perception problems
- Having any musculoskeletal injury in the last 6 months
- Having pain in the upper extremity and a history of surgery
- Participating in upper extremity weight training in the last 6 months
- Those taking anti-inflammatory or analgesic medications up to 12 hours before evaluation
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Necmettin Erbakan University
Konya, Meram, 42140
About this study
Official title: Effect of Manual Lymphatic Drainage and Kinesio Taping on Delayed Onset Muscle Soreness: Randomized -Controlled Study
Delayed muscle soreness is pain and tenderness that occurs after unusual exercises, most often involving eccentric contraction. This sensitivity, which usually begins in the distal part of the muscle and is intense, spreads progressively throughout the entire muscle 24-48 hours after exercise. The intensity of the discomfort increases within the first 24 hours following cessation of exercise, peaks between 24 and 72 hours, decreases and eventually disappears within 5-7 days after exercise.
Delayed onset muscle soreness is considered one of the most common and recurring forms of sports injuries. The most prominent symptoms and findings are a decrease in joint range of motion and strength, edema, stiffness, pain and tenderness. In the planned study, the investigatorss aimed to compare the effects of kinesio taping, manual drainage, placebo kinesio taping and placebo kinesio taping on pain intensity, pain threshold and tolerance, sensory sensitivity and connective tissue stiffness in individuals with delayed-onset muscle soreness.48 healthy adults will be included in our study. Participants will be divided into four groups of 12 people: kinesio taping, placebo kinesio taping, manual lymph drainage and placebo manual lymph drainage. Our participants will have a maximum repetition weight on their wrist flexor muscles, and a delayed muscle soreness protocol will be applied using 80% of this amount. In our participants, pain at rest and activity (VAS), pressure pain threshold and tolerance (algometer), tactile sense (Semmes-Weinstein Monofilament Test), edema (circumference measurement with tape measure), treatment satisfaction and effect (VAS), tissue tension (skin rolling). and perceived fatigue (VAS) will be evaluated. The researchers plan to conduct 5 assessments: before the delayed-onset muscle soreness protocol, immediately after the protocol, immediately after treatment, and 24 hours and 48 hours after the initial assessment.
Read the detailed description
Volunteers, healthcare students and university employees between the ages of 18-40 who meet the inclusion criteria will be included in our study. All participants meeting the inclusion criteria will be selected and divided into four groups using computer-generated randomization (simple randomization) ( www.randomizer.org ).Participants will be divided into four groups: manual lymph drainage, placebo manual lymph drainage, kinesio taping and placebo kinesio taping.
On the first day, after the volunteers who meet the inclusion criteria are divided into groups, demographic information (gender, age, height, body weight) will be collected. The first evaluation will be made after demographic information is obtained. The evaluation includes pain at rest and activity (VAS), pressure pain threshold and tolerance (algometer), tactile sense (Semmes-Weinstein Monofilament Test), edema (circumference measurement with tape measure), treatment satisfaction and effect (VAS), tissue tension and perceived fatigue. (VAS) will be evaluated. Visual Analog scale will be used to evaluate pain at rest and activity. Visual Analog Scale is a 10 cm long ruler drawn horizontally, starting with "No pain" and ending with "Unbearable pain". Our participants will be asked to mark an "x" in the appropriate area on this ruler for the intensity of pain they feel at rest. In order to determine the intensity of pain during the activity, the patient will be asked to perform wrist flexion and extension and will be asked to mark the pain they feel during the movement on the ruler in the same way. Algometer will be used to evaluate pressure pain threshold and tolerance. As the measurement point, the researcher will mark 5 cm distal to the medial epicondyle of the humerus on the line connecting the midpoint of the wrist joint and the medial epicondyle of the humerus . Two measurements will be made on this point with an interval of 30 seconds and the average will be recorded. Semmes-Weinstein Monofilament Test will be used for tactile sensation. The patient is asked to close his eyes while sitting with his forearm supported. The point where the pressure pain threshold was measured was chosen as the measurement point. Monofilament test is applied to the determined area a maximum of 3 times; Force is applied until the filament becomes slightly curved. The participant is told to say yes as soon as he feels it and the application is stopped at that moment. For each filament that is not felt, the next value, the thicker filament, is tried. Each filament is kept in the applied area for 1-1.5 seconds. The value obtained after the measurement is recorded. Edema measurement will be measured with a non-flexible tape measure at the reference point where the pressure pain threshold is measured, with the participant in a sitting position with forearm supported. Treatment satisfaction and impact will only be questioned at the final evaluation.Researchers will evaluate the patient's treatment satisfaction level with a visual analog scale. The patient will be asked to evaluate his/her satisfaction with the treatment by placing an "x" mark on the ruler, which starts with "I am not at all satisfied" and ends with "I am very satisfied". Tissue tension will be evaluated on the forearm with the skin rolling technique. Visual Analog scale will be used for perceived fatigue. "There is no fatigue at all." The patient will be asked to evaluate the fatigue he/she feels by placing an "x" on the ruler starting with "Severe Fatigue". All evaluations will be applied to the non-dominant upper extremity wrist flexor muscles. Because the researchers recruited healthy volunteers, they do not expect the participants to experience any pain at the start of the study.Researchers will create the muscle soreness they want using free weights. Researchers will find a 1 Maximum Rep Weight to create delayed onset muscle soreness. Researchers will reference previous studies to find a 1 Maximum Rep Weight.1 Maximum Repetition is the weight that can be lifted only once but cannot be lifted a second time. 1 After the Maximum Repetition weight is determined, an eccentric exercise program will be applied to the participants with a free weight of 80% of this weight. After the first evaluation, the 1 Maximum Repetition weight of the non-dominant wrist flexor muscles will be determined. 1 Mayhew et al.'s formula will be used to find Maximum Repetition. Participants will be given an estimated weight for their wrist flexors and counted the number of times they lift that weight. The resulting weight and number of repetitions will be substituted into the formula and 1 Maximum Repetition will be calculated. After 1 Maximum Repetition is determined, a delayed muscle soreness protocol will be applied by performing 10 sets of wrist flexion consisting of 10 repetitions at 80% of 1 Maximum Repetition. There will be a 1 minute rest period between each set. After delayed onset muscle soreness is established, participants will be given a second evaluation and then their treatments will be applied according to the groups they belong to. After the treatment, the third evaluation will be made and the first day applications will end. A fourth assessment will be made 24 hours after the delayed muscle soreness protocol and a fifth assessment will be made 48 hours later.All of the parameters described above will be evaluated in all five planned evaluations. Treatment satisfaction and impact will only be questioned at the final evaluation
- Conditions
- Delayed Onset Muscle Soreness
- Being tested
- kinesio taping, placebo kinesio taping, manual lymph drainage, placebo manual lymph drainage
- Keywords
- delayed onset muscle soreness, kinesio taping, manual lymphatic drainage, pressure pain threshold, pain
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
kinesio tapingOther
The 5 cm wide Kinesio tape (Kinesio® Tex Gold™, Albuquerque, NM) applied to the participants has the ability to stretch up to 140% of its original length. Moreover, it provides comfortable use for 3 to 5 days thanks to its latex-free, cotton, hypoallergenic and porous features. The skin will be cleaned with alcohol before applying Kinesio tape. To prevent muscle tension, the physiotherapist will apply the kinesio tape inhibition technique to the wrist flexor muscles with light tension (15-25% of the current tension) from the end point to the origin. We will use this inhibition technique to prevent muscle spasm. Kinesio taping will be applied immediately after exercise
placebo kinesio tapingOther
5 cm wide and 0.5 mm thick I-shaped Kinesio tape (Kinesio Tex® Gold) will be used. The tape will be applied in a plus-shaped, tension-free and technical sitting position. Kinesio taping will be applied immediately after exercise
manual lymph drainageOther
Participants will lie in a supine position with their knees bent. Manual lymphatic drainage will begin with abdominal lymph drainage followed by central lymph stimulation. Then, bilateral axillary lymph nodes will be stimulated and the fluid in the exercised arm will be directed to the axillary lymph nodes. While the patients are in the prone position, the axillary lymph nodes will be stimulated in the same way and each manual lymphatic drainage will be performed from the back to the axillary lymph node. Each treatment session will last approximately 30 minutes
placebo manual lymph drainageOther
Participants will lie in a supine position with their knees bent. It will only be moved in a stroking style with hand contact from the fingers towards the armpit.
| Study group | Role | What they receive |
|---|---|---|
| kinesio taping | Active comparator | Kinesio taping is a widely used physiotherapy application for muscle pain. Kinesio taping will be applied to patients in this group. Receives: Other: kinesio taping |
| placebo kinesio taping | Placebo comparator | Kinesio taping is a widely used physiotherapy application for muscle pain. In this group, placebo kinesio taping will be applied to the patients. Receives: Other: placebo kinesio taping |
| manual lymph drainage | Active comparator | Manual lymphatic drainage is a method commonly used in cases where lymph flow is impaired. Manual lymphatic drainage will be applied to patients in this group. Receives: Other: manual lymph drainage |
| placebo manual lymph drainage | Placebo comparator | Manual lymphatic drainage is a method commonly used in cases where lymph flow is impaired. In this group, patients will receive placebo manual lymphatic drainage. Receives: Other: placebo manual lymph drainage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain at rest and activity
It will be evaluated with a visual analog scale. Possible scores range from 0 (no pain) to 10 (worst possible pain)
Measured: Three days
Pressure pain threshold and tolerance
It will be measured with an algometer. The result will be displayed in pounds
Measured: Three days
Secondary outcomes (5)
Tactile sensation
Semmes-Weinstein Monofilament Test will be used for tactile sensation.Monofilament sets containing sizes 2.83, 3.61, 4.31, 4.56, 6.65 will be used.
Measured: Three days
Edema
Edema measurement will be made with a non-flexible tape measure. Will be recorded in centimeters
Measured: Three days
Tissue tension
Tissue tension will be evaluated on the forearm with the skin rolling technique. In all planned evaluations, the tension bands will be evaluated according to the amount of tension (sensitivity) felt by the individual and the amount of tension felt by the therapist as "none (0)", "mild (1)", "moderate (2)" and "severe (3)".
Measured: Three days
Treatment satisfaction and impact
It will be evaluated with a visual analog scale. It will be scored between 0 - 10. 0(I am not happy at all)- 10(I am completely satisfied)
Measured: One day
perceived fatigue
It will be evaluated with a visual analog scale. It will be scored between 0 - 10. 0(I'm not tired at all) - 10(I'm completely tired).
Measured: Three days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Aug 2024
- Study start23 Sep 2024
- Primary completion25 Sep 2024
- Study completion18 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Delayed Onset Muscle SorenessStudies of the same condition, open and under way.
- More trials run by Necmettin Erbakan UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- We conducted our study as a randomized controlled study. There will be no masking in our study.
- Masking
- None (open label)
- Enrolment
- 48 participants (actual)
Sponsor and investigators
- Lead sponsor
- Necmettin Erbakan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yavuz Özkan, Necmettin Erbakan University
- Investigators
- Yavuz Özkan, MSc, Principal investigator, Necmettin Erbakan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06535906
- Sponsor's protocol ID
- NEU-FTR-YO-01
- Status last verified
- Oct 2024
- First submitted
- 30 Jul 2024
- Last updated
- 29 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Manual Lymphatic Drainage and Kinesio Taping on Delayed Onset Muscle Soreness: Randomized -Controlled Study
- ClinicalTrials.gov ID
- NCT06535906
- Acronym / sponsor ID
- NEU-FTR-YO-01
- Conditions
- Delayed Onset Muscle Soreness
- Keywords
- delayed onset muscle soreness, kinesio taping, manual lymphatic drainage, pressure pain threshold, pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 48 participants (actual)
- Lead sponsor
- Necmettin Erbakan UniversityUniversity, hospital or other
- Study start
- 23 Sep 2024 (actual)
- Primary completion
- 25 Sep 2024 (actual)
- Study completion
- 18 Oct 2024 (actual)
- First posted
- 2 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Delayed muscle soreness is pain and tenderness that occurs after unusual exercises, most often involving eccentric contraction. This sensitivity, which usually begins in the distal part of the muscle and is intense, spreads progressively throughout the entire muscle 24-48 hours after exercise. The intensity of the discomfort increases within the first 24 hours following cessation of exercise, peaks between 24 and 72 hours, decreases and eventually disappears within 5-7 days after exercise.
Delayed onset muscle soreness is considered one of the most common and recurring forms of sports injuries. The most prominent symptoms and findings are a decrease in joint range of motion and strength, edema, stiffness, pain and tenderness. In the planned study, the investigatorss aimed to compare the effects of kinesio taping, manual drainage, placebo kinesio taping and placebo kinesio taping on pain intensity, pain threshold and tolerance, sensory sensitivity and connective tissue stiffness in individuals with delayed-onset muscle soreness.48 healthy adults will be included in our study. Participants will be divided into four groups of 12 people: kinesio taping, placebo kinesio taping, manual lymph drainage and placebo manual lymph drainage. Our participants will have a maximum repetition weight on their wrist flexor muscles, and a delayed muscle soreness protocol will be applied using 80% of this amount. In our participants, pain at rest and activity (VAS), pressure pain threshold and tolerance (algometer), tactile sense (Semmes-Weinstein Monofilament Test), edema (circumference measurement with tape measure), treatment satisfaction and effect (VAS), tissue tension (skin rolling). and perceived fatigue (VAS) will be evaluated. The researchers plan to conduct 5 assessments: before the delayed-onset muscle soreness protocol, immediately after the protocol, immediately after treatment, and 24 hours and 48 hours after the initial assessment.
Detailed description
Volunteers, healthcare students and university employees between the ages of 18-40 who meet the inclusion criteria will be included in our study. All participants meeting the inclusion criteria will be selected and divided into four groups using computer-generated randomization (simple randomization) ( www.randomizer.org ).Participants will be divided into four groups: manual lymph drainage, placebo manual lymph drainage, kinesio taping and placebo kinesio taping.
On the first day, after the volunteers who meet the inclusion criteria are divided into groups, demographic information (gender, age, height, body weight) will be collected. The first evaluation will be made after demographic information is obtained. The evaluation includes pain at rest and activity (VAS), pressure pain threshold and tolerance (algometer), tactile sense (Semmes-Weinstein Monofilament Test), edema (circumference measurement with tape measure), treatment satisfaction and effect (VAS), tissue tension and perceived fatigue. (VAS) will be evaluated. Visual Analog scale will be used to evaluate pain at rest and activity. Visual Analog Scale is a 10 cm long ruler drawn horizontally, starting with "No pain" and ending with "Unbearable pain". Our participants will be asked to mark an "x" in the appropriate area on this ruler for the intensity of pain they feel at rest. In order to determine the intensity of pain during the activity, the patient will be asked to perform wrist flexion and extension and will be asked to mark the pain they feel during the movement on the ruler in the same way. Algometer will be used to evaluate pressure pain threshold and tolerance. As the measurement point, the researcher will mark 5 cm distal to the medial epicondyle of the humerus on the line connecting the midpoint of the wrist joint and the medial epicondyle of the humerus . Two measurements will be made on this point with an interval of 30 seconds and the average will be recorded. Semmes-Weinstein Monofilament Test will be used for tactile sensation. The patient is asked to close his eyes while sitting with his forearm supported. The point where the pressure pain threshold was measured was chosen as the measurement point. Monofilament test is applied to the determined area a maximum of 3 times; Force is applied until the filament becomes slightly curved. The participant is told to say yes as soon as he feels it and the application is stopped at that moment. For each filament that is not felt, the next value, the thicker filament, is tried. Each filament is kept in the applied area for 1-1.5 seconds. The value obtained after the measurement is recorded. Edema measurement will be measured with a non-flexible tape measure at the reference point where the pressure pain threshold is measured, with the participant in a sitting position with forearm supported. Treatment satisfaction and impact will only be questioned at the final evaluation.Researchers will evaluate the patient's treatment satisfaction level with a visual analog scale. The patient will be asked to evaluate his/her satisfaction with the treatment by placing an "x" mark on the ruler, which starts with "I am not at all satisfied" and ends with "I am very satisfied". Tissue tension will be evaluated on the forearm with the skin rolling technique. Visual Analog scale will be used for perceived fatigue. "There is no fatigue at all." The patient will be asked to evaluate the fatigue he/she feels by placing an "x" on the ruler starting with "Severe Fatigue". All evaluations will be applied to the non-dominant upper extremity wrist flexor muscles. Because the researchers recruited healthy volunteers, they do not expect the participants to experience any pain at the start of the study.Researchers will create the muscle soreness they want using free weights. Researchers will find a 1 Maximum Rep Weight to create delayed onset muscle soreness. Researchers will reference previous studies to find a 1 Maximum Rep Weight.1 Maximum Repetition is the weight that can be lifted only once but cannot be lifted a second time. 1 After the Maximum Repetition weight is determined, an eccentric exercise program will be applied to the participants with a free weight of 80% of this weight. After the first evaluation, the 1 Maximum Repetition weight of the non-dominant wrist flexor muscles will be determined. 1 Mayhew et al.'s formula will be used to find Maximum Repetition. Participants will be given an estimated weight for their wrist flexors and counted the number of times they lift that weight. The resulting weight and number of repetitions will be substituted into the formula and 1 Maximum Repetition will be calculated. After 1 Maximum Repetition is determined, a delayed muscle soreness protocol will be applied by performing 10 sets of wrist flexion consisting of 10 repetitions at 80% of 1 Maximum Repetition. There will be a 1 minute rest period between each set. After delayed onset muscle soreness is established, participants will be given a second evaluation and then their treatments will be applied according to the groups they belong to. After the treatment, the third evaluation will be made and the first day applications will end. A fourth assessment will be made 24 hours after the delayed muscle soreness protocol and a fifth assessment will be made 48 hours later.All of the parameters described above will be evaluated in all five planned evaluations. Treatment satisfaction and impact will only be questioned at the final evaluation
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
- Model description
- We conducted our study as a randomized controlled study. There will be no masking in our study.
| Arm | Type | Receives |
|---|---|---|
| kinesio taping | Active comparator | Other: kinesio tapingKinesio taping is a widely used physiotherapy application for muscle pain. Kinesio taping will be applied to patients in this group. |
| placebo kinesio taping | Placebo comparator | Other: placebo kinesio tapingKinesio taping is a widely used physiotherapy application for muscle pain. In this group, placebo kinesio taping will be applied to the patients. |
| manual lymph drainage | Active comparator | Other: manual lymph drainageManual lymphatic drainage is a method commonly used in cases where lymph flow is impaired. Manual lymphatic drainage will be applied to patients in this group. |
| placebo manual lymph drainage | Placebo comparator | Other: placebo manual lymph drainageManual lymphatic drainage is a method commonly used in cases where lymph flow is impaired. In this group, patients will receive placebo manual lymphatic drainage. |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Being between the ages of 18-40
- Agreeing to participate in the study
- Being healthy sedentary
Key exclusion criteria (5 listed)
- Those with neurological or perception problems
- Having any musculoskeletal injury in the last 6 months
- Having pain in the upper extremity and a history of surgery
- Participating in upper extremity weight training in the last 6 months
- Those taking anti-inflammatory or analgesic medications up to 12 hours before evaluation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| kinesio tapingThe 5 cm wide Kinesio tape (Kinesio® Tex Gold™, Albuquerque, NM) applied to the participants has the ability to stretch up to 140% of its original length. Moreover, it provides comfortable use for 3 to 5 days thanks to its latex-free, cotton, hypoallergenic and porous features. The skin will be cleaned with alcohol before applying Kinesio tape. To prevent muscle tension, the physiotherapist will apply the kinesio tape inhibition technique to the wrist flexor muscles with light tension (15-25% of the current tension) from the end point to the origin. We will use this inhibition technique to prevent muscle spasm. Kinesio taping will be applied immediately after exercise | Other | kinesio taping |
| placebo kinesio taping5 cm wide and 0.5 mm thick I-shaped Kinesio tape (Kinesio Tex® Gold) will be used. The tape will be applied in a plus-shaped, tension-free and technical sitting position. Kinesio taping will be applied immediately after exercise | Other | placebo kinesio taping |
| manual lymph drainageParticipants will lie in a supine position with their knees bent. Manual lymphatic drainage will begin with abdominal lymph drainage followed by central lymph stimulation. Then, bilateral axillary lymph nodes will be stimulated and the fluid in the exercised arm will be directed to the axillary lymph nodes. While the patients are in the prone position, the axillary lymph nodes will be stimulated in the same way and each manual lymphatic drainage will be performed from the back to the axillary lymph node. Each treatment session will last approximately 30 minutes | Other | manual lymph drainage |
| placebo manual lymph drainageParticipants will lie in a supine position with their knees bent. It will only be moved in a stroking style with hand contact from the fingers towards the armpit. | Other | placebo manual lymph drainage |
Primary outcome
Pain at rest and activity
Time frame: Three days
It will be evaluated with a visual analog scale. Possible scores range from 0 (no pain) to 10 (worst possible pain)
Pressure pain threshold and tolerance
Time frame: Three days
It will be measured with an algometer. The result will be displayed in pounds
5 secondary outcomes
Tactile sensation
Time frame: Three days
Edema
Time frame: Three days
Tissue tension
Time frame: Three days
Treatment satisfaction and impact
Time frame: One day
perceived fatigue
Time frame: Three days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Delayed Onset Muscle Soreness
Recruiting
Mineral-Infused Clothing for Recovery From Muscle Soreness and Muscle Damage After Exercise
Delayed Onset Muscle Soreness, Exercise-Induced Muscle Damage
Not yet recruiting
Clinical and MRI Characteristics of Delayed Onset Muscle Soreness (DOMS) of the Shoulder Rotator Muscles Induced by Eccentric Exercise: An Exploratory Prospective Experimental Study
Delayed Onset Muscle Soreness Experimentally Induced
Recruiting
Effects of Kinesio Tape on Delayed Onset Muscle Soreness
Delayed Onset Muscle Soreness
Not yet recruiting
Therapeutic Ultrasound for Muscle Recovery After Muscle Fatigue Exercise
Muscle Fatigue (C23.888.592.612.612), Delayed Onset Muscle Soreness (DOMS)
Not yet recruiting
Mogrosides for Delayed-Onset Muscle Soreness
Delayed-Onset Muscle Soreness (DOMS)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yavuz Özkan, MSc principal investigator
Necmettin Erbakan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing kinesio taping and manual lymph drainage in people with Delayed Onset Muscle Soreness, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain at rest and activity (time frame: Three days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2024; AzTrials last refreshed its copy on 7 Nov 2026.